Highly efficient electro-gene therapy of solid tumor by using an expression plasmid for the herpes simplex virus thymidine kinase gene

AUTOR(ES)

Goto, Tomoaki

FONTE

The National Academy of Sciences

RESUMO

We report successful electro-gene therapy (EGT) by using plasmid DNA for tumor-bearing mice. Subcutaneously inoculated CT26 tumor was subjected to EGT, which consists of intratumoral injection of a naked plasmid encoding a marker gene or a therapeutic gene, followed by in vivo electroporation (EP). When this treatment modality is carried out with the plasmid DNA for the green fluorescent protein gene, followed by in vivo EP with the optimized pulse parameters, numerous intensely bright green fluorescent signals appeared within the tumor. EGT, by using the “A” fragment of the diphtheria toxin gene significantly inhibited the growth of tumors, by about 30%, on the flank of mice. With the herpes simplex virus thymidine kinase gene, followed by systemic injection of ganciclovir, EGT was far more effective in retarding tumor growth, varying between 50% and 90%, compared with the other controls. Based on these results, it appears that EGT can be used successfully for treating murine solid tumors.

Documentos Relacionados

• Identification of sequences in the herpes simplex virus thymidine kinase gene required for efficient processing and polyadenylation.
• Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy.
• Initiator elements and regulated expression of the herpes simplex virus thymidine kinase gene.
• Herpes simplex virus transactivator ICP4 operationally substitutes for the cellular transcription factor Sp1 for efficient expression of the viral thymidine kinase gene.
• Inhibition of herpes simplex thymidine kinase gene expression by DNA methylation is an indirect effect.